The DOI matches its Crossref record.
Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In people with H. pylori, the use of 2100 mg/day curcumin extract was associated with a significantly lower likelihood of eradication of H. pylori compared to triple therapy after 6 weeks of treatment (curcumin vs. triple therapy: 5.9% vs. 78.9%;p < 0.001) (Koosirirat et al., 2010).”
From A systematic review of the efficacy and safety of turmeric in the treatment of digestive disorders (2024) · cites this paper as Koosirirat et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 25
- D'Elios, 2005, Helicobacter pylori, T cells and cytokines: the “dangerous liaisons”, FEMS Immunol Med Microbiol, 44, 113, 10.1016/j.femsim.2004.10.013 · DOI
- Nakachi, 2000, Helicobacter pylori infection of human gastric epithelial cells induces IL-8 and TNFalpha, but not TGFbeta1 mRNA, FEMS Immunol Med Microbiol, 29, 23
- Naito, 2008, Expression of inducible nitric oxide synthase and nitric oxide-modified proteins in Helicobacter pylori-associated atrophic gastric mucosa, J Gastroenterol Hepatol, 23, S250, 10.1111/j.1440-1746.2008.05412.x · DOI
- Fu, 1999, Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis, Gastroenterology, 116, 1319, 10.1016/S0016-5085(99)70496-8 · DOI · Paper page
- Peek, 2001, IV. Helicobacter pylori strain-specific activation of signal transduction cascades related to gastric inflammation, Am J Physiol Gastrointest Liver Physiol, 280, G525, 10.1152/ajpgi.2001.280.4.G525 · DOI
- Sharma, 1998, Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells, J Immunol, 160, 2401, 10.4049/jimmunol.160.5.2401 · DOI
- Goodwin, 1997, Helicobacter pylori infection, Lancet, 349, 265, 10.1016/S0140-6736(96)07023-7 · DOI
- Kabir, 2009, Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events, Helicobacter, 14, 159, 10.1111/j.1523-5378.2009.00677.x · DOI
- O'Connor, 2009, Treatment of Helicobacter pylori infection, Helicobacter, 14, 46, 10.1111/j.1523-5378.2009.00704.x · DOI
- Gisbert, 2004, Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study, Hepatogastroenterology, 51, 303
- Di Mario, 2007, A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure?, Helicobacter, 12, 238, 10.1111/j.1523-5378.2007.00497.x · DOI
- Koosirirat, 2007, Helicobacter pylori eradication with cucumin versus omeprazole-based triple therapy, an open randomized controlled trial, Uttaradite Hospita Med Bull, 22, 43
- Wittayasatiankul, 2003, Helicobacter pylori eradication with curcumin: a pilot study, Uttaradit Hospital Med Bull, 18, 1
- Foryst-Ludwig, 2004, Curcumin blocks NF-kappaB and the motogenic response in Helicobacter pylori-infected epithelial cells, Biochem Biophys Res Commun, 316, 1065, 10.1016/j.bbrc.2004.02.158 · DOI
- Sumanont, 2007, Effects of manganese complexes of curcumin and diacetylcurcumin on kainic acid-induced neurotoxic responses in the rat hippocampus, Biol Pharm Bull, 30, 1732, 10.1248/bpb.30.1732 · DOI
- Camacho-Barquero, 2007, Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis, Int Immunopharmacol, 7, 333, 10.1016/j.intimp.2006.11.006 · DOI · Paper page
- Kuhad, 2007, Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity, J Agric Food Chem, 55, 10150, 10.1021/jf0723965 · DOI
- Mahady, 2002, Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen, Anticancer Res, 22, 4179
- Goel, 2008, Curcumin as “Curecumin”: from kitchen to clinic, Biochem Pharmacol, 75, 787, 10.1016/j.bcp.2007.08.016 · DOI
- Jurenka, 2009, Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research, Altern Med Rev, 14, 141
- Cho, 2009, Zedoarondiol isolated from the rhizoma of Curcuma heyneana is involved in the inhibition of iNOS, COX-2 and pro-inflammatory cytokines via the downregulation of NF-kappaB pathway in LPS-stimulated murine macrophages, Int Immunopharmacol, 9, 1049, 10.1016/j.intimp.2009.04.012 · DOI
- Ferrero, 2008, NF-kappaB activation during acute Helicobacter pylori infection in mice, Infect Immun, 76, 551, 10.1128/IAI.01107-07 · DOI
- Cogswell, 1994, NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site, J Immunol, 153, 712, 10.4049/jimmunol.153.2.712 · DOI
- Uemura, 1997, Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer, Cancer Epidemiol Biomarkers Prev, 6, 639
- Kim, 2005, Curcuma longa extract protects against gastric ulcers by blocking H2 histamine receptors, Biol Pharm Bull, 28, 2220, 10.1248/bpb.28.2220 · DOI
Cited by
A systematic review of the efficacy and safety of turmeric in the treatment of digestive disorders
Thavorn, K., Wolfe, D., Faust, L., Shorr, R., Akkawi, M., Isaranuwatchai, W., Klinger, C., Chai‐Adisaksopa, C., Tanvejsilp, P., Nochaiwong, S., et al. (2024) · Phytotherapy Research · doi:10.1002/ptr.8189 · Cited by 11
Metadata
- Authors
- Koosirirat, C., Linpisarn, S., Changsom, D., Chawansuntati, K., & Wipasa, J.
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 10
- Issue
- 7
- Pages
- 815-818
- ISSN
- 1567-5769
- Cited by
- 99
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
